IMMUNITYBIO, INC. Depreciation and Amortization
IMMUNITYBIO, INC. (IBRX) reported Depreciation and Amortization of $8.79 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DepreciationDepletionAndAmortization · last filed 2026-08-04
- IMMUNITYBIO, INC. depreciation, depletion and amortization for the quarter ending 2026-06-30 was $4.41M, a 13.58% increase year-over-year.
- IMMUNITYBIO, INC. depreciation, depletion and amortization for the quarter ending 2026-03-31 was $4.38M, a 14.39% increase year-over-year.
- IMMUNITYBIO, INC. depreciation, depletion and amortization for the quarter ending 2025-12-31 was $3.87M, a 6.60% decline year-over-year.
- IMMUNITYBIO, INC. depreciation, depletion and amortization for the quarter ending 2025-09-30 was $3.95M, a 11.31% decline year-over-year.
- IMMUNITYBIO, INC. depreciation, depletion and amortization for fiscal 2025 was $15.53M, a 11.56% decline from fiscal 2024.
- IMMUNITYBIO, INC. depreciation, depletion and amortization for fiscal 2024 was $17.55M, a 5.18% decline from fiscal 2023.
- IMMUNITYBIO, INC. depreciation, depletion and amortization for fiscal 2023 was $18.51M, a 1.38% increase from fiscal 2022.
- IMMUNITYBIO, INC. depreciation, depletion and amortization for fiscal 2022 was $18.26M, a 28.25% increase from fiscal 2021.
| Period end | Depreciation, Depletion and Amortization 3 month | Depreciation, Depletion and Amortization 3 month as first filed | Depreciation, Depletion and Amortization 6 month | Depreciation, Depletion and Amortization 6 month as first filed | Depreciation, Depletion and Amortization 9 month | Depreciation, Depletion and Amortization 9 month as first filed | Depreciation, Depletion and Amortization 12 month | Depreciation, Depletion and Amortization 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $8.79M 10-Q · filed 2026-08-04 | $12.65M derived: sum of 3 quarters · filed 2026-08-04 | $16.60M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $4.38M 10-Q · filed 2026-05-07 | $8.24M derived: sum of 2 quarters · filed 2026-05-07 | $12.20M derived: sum of 3 quarters · filed 2026-05-07 | $16.08M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $3.87M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $7.82M derived: sum of 2 quarters · filed 2026-02-23 | $11.70M derived: sum of 3 quarters · filed 2026-08-04 | $15.53M 10-K · filed 2026-02-23 | ||||
| 2025-09-30 | $3.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $7.83M derived: sum of 2 quarters · filed 2026-08-04 | $11.66M 10-Q · filed 2025-11-05 | $15.80M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $3.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $7.71M 10-Q · filed 2026-08-04 | $11.85M derived: sum of 3 quarters · filed 2026-08-04 | $16.30M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $3.83M 10-Q · filed 2026-05-07 | $7.97M derived: sum of 2 quarters · filed 2026-05-07 | $12.42M derived: sum of 3 quarters · filed 2026-05-07 | $16.83M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $4.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $8.59M derived: sum of 2 quarters · filed 2026-02-23 | $13.00M derived: sum of 3 quarters · filed 2026-02-23 | $17.55M 10-K · filed 2026-02-23 | ||||
| 2024-09-30 | $4.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $8.86M derived: sum of 2 quarters · filed 2025-11-05 | $13.42M 10-Q · filed 2025-11-05 | $17.98M derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2024-06-30 | $4.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $8.96M 10-Q · filed 2025-08-05 | $13.53M derived: sum of 3 quarters · filed 2026-02-23 | $18.11M derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2024-03-31 | $4.55M 10-Q · filed 2025-05-12 | $9.12M derived: sum of 2 quarters · filed 2026-02-23 | $13.70M derived: sum of 3 quarters · filed 2026-02-23 | $18.39M derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2023-12-31 | $4.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $9.15M derived: sum of 2 quarters · filed 2026-02-23 | $13.83M derived: sum of 3 quarters · filed 2026-02-23 | $18.51M 10-K · filed 2026-02-23 | ||||
| 2023-09-30 | $4.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $9.27M derived: sum of 2 quarters · filed 2024-11-12 | $13.95M 10-Q · filed 2024-11-12 | $19.17M derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2023-06-30 | $4.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $9.36M 10-Q · filed 2024-08-12 | $14.59M derived: sum of 3 quarters · filed 2025-03-03 | $19.09M derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2023-03-31 | $4.68M 10-Q · filed 2024-05-09 | $9.91M derived: sum of 2 quarters · filed 2025-03-03 | $14.41M derived: sum of 3 quarters · filed 2025-03-03 | $18.85M derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2022-12-31 | $5.23M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $9.73M derived: sum of 2 quarters · filed 2025-03-03 | $14.17M derived: sum of 3 quarters · filed 2025-03-03 | $18.26M 10-K · filed 2025-03-03 | ||||
| 2022-09-30 | $4.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $8.94M derived: sum of 2 quarters · filed 2023-11-09 | $13.03M 10-Q · filed 2023-11-09 | $16.63M derived: sum of 4 quarters · filed 2024-03-19 | ||||
| 2022-06-30 | $4.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $8.53M 10-Q · filed 2023-08-08 | $12.13M derived: sum of 3 quarters · filed 2024-03-19 | $15.82M derived: sum of 4 quarters · filed 2024-03-19 | ||||
| 2022-03-31 | $4.09M 10-Q · filed 2023-05-11 | $7.68M derived: sum of 2 quarters · filed 2024-03-19 | $11.37M derived: sum of 3 quarters · filed 2024-03-19 | $15.36M derived: sum of 4 quarters · filed 2024-03-19 | ||||
| 2021-12-31 | $3.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $7.28M derived: sum of 2 quarters · filed 2024-03-19 | $11.27M derived: sum of 3 quarters · filed 2024-03-19 | $14.24M 10-K · filed 2024-03-19 | ||||
| 2021-09-30 | $3.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $7.67M derived: sum of 2 quarters · filed 2022-11-09 | $10.64M 10-Q · filed 2022-11-09 | $12.87M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-06-30 | $3.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $6.96M 10-Q · filed 2022-08-08 | $9.18M derived: sum of 3 quarters · filed 2023-03-01 | $12.74M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-03-31 | $2.97M 10-Q · filed 2022-05-10 | $5.20M derived: sum of 2 quarters · filed 2023-03-01 | $8.75M derived: sum of 3 quarters · filed 2023-03-01 | $12.25M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2020-12-31 | $2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $5.78M derived: sum of 2 quarters · filed 2023-03-01 | $9.28M derived: sum of 3 quarters · filed 2023-03-01 | $12.74M 10-K · filed 2023-03-01 | $9.15M 10-K · filed 2021-03-04 | |||
| 2020-09-30 | $3.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $7.05M derived: sum of 2 quarters · filed 2021-11-12 | $10.51M 10-Q · filed 2021-11-12 | $6.86M 10-Q · filed 2020-11-09 | $17.75M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-06-30 | $3.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $6.96M 10-Q · filed 2021-08-12 | $4.48M 10-Q · filed 2020-08-07 | $14.20M derived: sum of 3 quarters · filed 2022-03-01 | $16.40M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-03-31 | $3.46M 10-Q · filed 2021-05-14 | $2.22M 10-Q · filed 2020-05-11 | $10.70M derived: sum of 2 quarters · filed 2022-03-01 | $12.90M derived: sum of 3 quarters · filed 2022-03-01 | $15.11M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2019-12-31 | $7.24M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $9.44M derived: sum of 2 quarters · filed 2022-03-01 | $11.65M derived: sum of 3 quarters · filed 2022-03-01 | $14.04M 10-K · filed 2022-03-01 | $9.01M 10-K · filed 2020-03-25 | |||
| 2019-09-30 | $2.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $4.41M derived: sum of 2 quarters · filed 2020-11-09 | $6.80M 10-Q · filed 2020-11-09 | $9.59M derived: sum of 4 quarters · filed 2021-03-04 | ||||
| 2019-06-30 | $2.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $4.60M 10-Q · filed 2020-08-07 | $7.39M derived: sum of 3 quarters · filed 2021-03-04 | $10.16M derived: sum of 4 quarters · filed 2021-03-04 | ||||
| 2019-03-31 | $2.40M 10-Q · filed 2020-05-11 | $5.18M derived: sum of 2 quarters · filed 2021-03-04 | $7.96M derived: sum of 3 quarters · filed 2021-03-04 | $10.33M derived: sum of 4 quarters · filed 2021-03-04 | ||||
| 2018-12-31 | $2.79M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $5.56M derived: sum of 2 quarters · filed 2021-03-04 | $7.93M derived: sum of 3 quarters · filed 2021-03-04 | $9.55M 10-K · filed 2021-03-04 | ||||
| 2018-09-30 | $2.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $5.14M derived: sum of 2 quarters · filed 2019-11-05 | $6.77M 10-Q · filed 2019-11-05 | $8.34M derived: sum of 4 quarters · filed 2020-03-25 | ||||
| 2018-06-30 | $2.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $3.99M 10-Q · filed 2019-08-06 | $5.56M derived: sum of 3 quarters · filed 2020-03-25 | $7.02M derived: sum of 4 quarters · filed 2020-03-25 | ||||
| 2018-03-31 | $1.62M 10-Q · filed 2019-05-08 | $3.19M derived: sum of 2 quarters · filed 2020-03-25 | $4.65M derived: sum of 3 quarters · filed 2020-03-25 | $6.03M derived: sum of 4 quarters · filed 2020-03-25 | ||||
| 2017-12-31 | $1.57M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $3.03M derived: sum of 2 quarters · filed 2020-03-25 | $4.40M derived: sum of 3 quarters · filed 2020-03-25 | $5.57M 10-K · filed 2020-03-25 | ||||
| 2017-09-30 | $1.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $2.83M derived: sum of 2 quarters · filed 2018-11-07 | $4.00M 10-Q · filed 2018-11-07 | $5.84M derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2017-06-30 | $1.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $2.54M 10-Q · filed 2018-08-06 | $4.38M derived: sum of 3 quarters · filed 2019-03-13 | $5.14M derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2017-03-31 | $1.16M 10-Q · filed 2018-05-07 | $3.00M derived: sum of 2 quarters · filed 2019-03-13 | $3.77M derived: sum of 3 quarters · filed 2019-03-13 | $4.28M derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2016-12-31 | $1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $2.61M derived: sum of 2 quarters · filed 2019-03-13 | $3.12M derived: sum of 3 quarters · filed 2019-03-13 | $3.61M 10-K · filed 2019-03-13 | ||||
| 2016-09-30 | $770.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $1.28M derived: sum of 2 quarters · filed 2017-11-07 | $1.77M 10-Q · filed 2017-11-07 | $2.26M derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2016-06-30 | $513.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $998.00K 10-Q · filed 2017-08-07 | $1.49M derived: sum of 3 quarters · filed 2018-03-12 | $1.48M derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2016-03-31 | $485.00K 10-Q · filed 2017-05-08 | $976.00K derived: sum of 2 quarters · filed 2018-03-12 | $971.00K derived: sum of 3 quarters · filed 2018-03-12 | $1.93M derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2015-12-31 | $491.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $486.00K derived: sum of 2 quarters · filed 2018-03-12 | $1.45M derived: sum of 3 quarters · filed 2018-03-12 | $1.47M 10-K · filed 2018-03-12 | ||||
| 2015-09-30 | -$5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $955.00K derived: sum of 2 quarters · filed 2016-11-10 | $981.00K 10-Q · filed 2016-11-10 | $1.07M 10-Q · filed 2015-11-12 | $938.00K derived: sum of 4 quarters · filed 2017-03-15 | |||
| 2015-06-30 | $960.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $986.00K 10-Q · filed 2016-08-15 | $1.04M 10-Q · filed 2015-09-10 | $943.00K derived: sum of 3 quarters · filed 2017-03-15 | $959.00K derived: sum of 4 quarters · filed 2017-03-15 | |||
| 2015-03-31 | $26.00K 10-Q · filed 2016-05-16 | -$17.00K derived: sum of 2 quarters · filed 2017-03-15 | -$1.00K derived: sum of 3 quarters · filed 2017-03-15 | $31.00K derived: sum of 4 quarters · filed 2017-03-15 | ||||
| 2014-12-31 | -$43.00K derived: 10-K 12 month − 10-K 9 month · filed 2017-03-15 | -$27.00K derived: sum of 2 quarters · filed 2017-03-15 | $5.00K derived: sum of 3 quarters · filed 2017-03-15 | $36.00K 10-K · filed 2017-03-15 | ||||
| 2014-09-30 | $16.00K derived: 10-K 9 month − 10-K 6 month · filed 2016-03-30 | $48.00K derived: sum of 2 quarters · filed 2016-03-30 | $79.00K 10-K · filed 2016-03-30 | $145.00K 10-Q · filed 2015-11-12 | ||||
| 2014-06-30 | $32.00K derived: 10-K 6 month − 10-K 3 month · filed 2016-03-30 | $63.00K 10-K · filed 2016-03-30 | $103.00K 10-Q · filed 2015-09-10 | |||||
| 2014-03-31 | $31.00K 10-K · filed 2016-03-30 | |||||||
| 2013-12-31 | $4.00K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |